Published in Science on March 18, 1983
The ail locus is found uniquely in Yersinia enterocolitica serotypes commonly associated with disease. Infect Immun (1989) 3.75
The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J Bacteriol (2000) 1.68
Urticaria and infections. Allergy Asthma Clin Immunol (2009) 1.28
Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease. Clin Exp Immunol (1986) 1.18
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev (2013) 1.05
Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol (1986) 1.03
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci (2014) 1.03
Autoimmunity: a decision theory model. J Clin Pathol (1987) 0.96
Communication between Bacteria and Their Hosts. Scientifica (Cairo) (2013) 0.85
Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease. Clin Exp Immunol (2003) 0.83
Monoclonal IgM from patients with peripheral demyelinating neuropathies cross-react with bacterial polypeptides. Clin Exp Immunol (1994) 0.78
Intragenic DNA spacers interrupt the ovalbumin gene. Proc Natl Acad Sci U S A (1978) 11.03
An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature (1994) 8.60
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68
Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med (1976) 5.78
Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis (1972) 4.54
Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. J Immunol (1973) 4.49
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol (1977) 4.46
Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A (1987) 3.99
Yersinia enterocolitica (Pasteurella x) in human enteric infections. Br Med J (1966) 3.87
Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest (1970) 3.64
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis (1977) 3.62
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition. J Infect Dis (1976) 3.20
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med (1988) 3.14
Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10
The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med (1992) 2.99
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest (1990) 2.96
Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med (1977) 2.95
PaxDb, a database of protein abundance averages across all three domains of life. Mol Cell Proteomics (2012) 2.93
Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A (1999) 2.89
Structural features of polysaccharides that induce intra-abdominal abscesses. Science (1993) 2.86
Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature (2001) 2.79
Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun (1992) 2.73
Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci U S A (1992) 2.65
Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet (1998) 2.57
Health seeking and perceived causes of tuberculosis among patients in Manila, Philippines. Trop Med Int Health (2000) 2.56
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system. Mol Cell Biol (1987) 2.52
Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis (1999) 2.50
Sensitized sheep red cells as a reactant for Staphylococcus aureus protein A. Methodology and epidemiology with special reference to weakly reacting methicillin-resistant strains. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 2.49
Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J Infect Dis (1973) 2.47
Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med (1966) 2.46
Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. J Clin Invest (1977) 2.46
Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis (1976) 2.45
Chronic poisoning by copper in tap water: I. Copper intoxications with predominantly gastointestinal symptoms. Eur J Med Res (1999) 2.43
Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun (1972) 2.43
Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis. J Infect Dis (1975) 2.39
Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun (1976) 2.38
Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem (1987) 2.35
Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc Natl Acad Sci U S A (1996) 2.34
Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J Biol Chem (2001) 2.30
A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J Clin Invest (1965) 2.29
In whose best interest? Breaching the academic-industrial wall. N Engl J Med (2000) 2.28
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun (1993) 2.26
Stimulation by phagocytosis of the deiodination of L-thyroxine in human leukocytes. Science (1972) 2.26
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23
Studies on the interaction between different O-serotypes of Yersinia enterocolitica and HeLa cells. Acta Pathol Microbiol Scand B (1979) 2.20
Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry (1981) 2.17
Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A (1989) 2.13
A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun (1991) 2.06
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol (2010) 2.02
The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem (1992) 2.00
Chronic poisoning by copper in tap water: II. Copper intoxications with predominantly systemic symptoms. Eur J Med Res (1999) 1.99
Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry (1992) 1.98
Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun (1991) 1.97
Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun (1991) 1.95
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
The changing spectrum of group B streptococcal disease. N Engl J Med (1993) 1.94
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med (1997) 1.93
Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest (1995) 1.91
Sorting of Golgi resident proteins into different subpopulations of COPI vesicles: a role for ArfGAP1. J Cell Biol (2001) 1.89
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83
Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus. Can J Biochem (1980) 1.83
Ventilation with low tidal volumes during upper abdominal surgery does not improve postoperative lung function. Br J Anaesth (2012) 1.82
Neonatal mouse model of group B streptococcal infection. J Infect Dis (1992) 1.82
Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int (1993) 1.80
Mouse protection test for group B Streptococcus type III. J Infect Dis (1979) 1.80
A review of recent neurochemical data on inert gas narcosis. Undersea Hyperb Med (2011) 1.75
Group B streptococcal vaccines. Rev Infect Dis (1985) 1.74
Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis (1977) 1.74
Closed tracheal suction and fluid aspiration past the tracheal tube. Impact of tube cuff and airway pressure. Minerva Anestesiol (2011) 1.73
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71
Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter. N Engl J Med (1969) 1.70
Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. J Pediatr (1980) 1.69
Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol (1995) 1.68
Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock. Intensive Care Med (2001) 1.66
Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals. J Cell Biol (1995) 1.64
Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun (1991) 1.64
Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature. Hum Pathol (2003) 1.64
Products of two common alleles at the locus for human placental alkaline phosphatase differ by seven amino acids. Proc Natl Acad Sci U S A (1986) 1.63
NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives. Biochemistry (1997) 1.63
Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med (1982) 1.62
Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab (1975) 1.62
The criterion validity of the Geriatric Depression Scale: a systematic review. Acta Psychiatr Scand (2006) 1.61
Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr (1979) 1.61
Liver-specific RNA metabolism in hepatoma cells: variations in transcription rates and mRNA levels. Mol Cell Biol (1985) 1.60
Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins. J Clin Invest (1982) 1.60
Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect Immun (2001) 1.59
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med (1999) 1.59
Purification and immunochemical characterization of the outer membrane complex of Bacteroides melaninogenicus subspecies asaccharolyticus. J Infect Dis (1977) 1.59
Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun (1992) 1.58
Bactericidal antibody assay using 14 C-labeled Neisseria meningitidis. Proc Soc Exp Biol Med (1972) 1.57
Bacterial capsule--old dogmas and new tricks. J Infect Dis (1986) 1.57
T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem (2000) 1.57
Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol (1986) 1.57
Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun (1999) 1.57
Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest (1982) 1.56
Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry (1983) 1.54